FTS3-01-04: FINAL EFFICACY, SAFETY AND BIOMARKER RESULTS OF THE PHASE 2B/3 RANDOMIZED, DOUBLE-BLINDED, PLACEBO-CONTROLLED EARLY TRIAL OF ATABECESTAT IN PRECLINICAL ALZHEIMER'S DISEASE
| Autor: | Paul S. Aisen, John Thipphawong, Keith Karcher, Karin Ernstrom, Hartmuth C. Kolb, Rema Raman, Gary Romano, Ziad S. Saad, Michael C. Donohue, Robert H. Brashear, Nandini Raghavan, Yevgen Tymofyeyev, Gerald Novak, Yingqi Shi, Reisa A. Sperling, David Henley |
|---|---|
| Rok vydání: | 2019 |
| Předmět: |
Oncology
medicine.medical_specialty Epidemiology Double blinded business.industry Health Policy Disease Placebo Psychiatry and Mental health Cellular and Molecular Neuroscience Developmental Neuroscience Internal medicine medicine Biomarker (medicine) Neurology (clinical) Geriatrics and Gerontology business |
| Zdroj: | Alzheimer's & Dementia. 15:P873-P874 |
| ISSN: | 1552-5260 |
| DOI: | 10.1016/j.jalz.2019.06.4621 |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|